{
  "id": 5429,
  "text": "Anticancer Drugs 1997;8:657-661.Available at: http://www.ncbi.nlm.nih.gov/pubmed/9311440.248.McGuire WP, Blessing JA, Moore D, et al.Paclitaxel has moderate activity in squamous cervix cancer.A Gynecologic Oncology Group study.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Anticancer Drugs 1997;8:657-661.Available at: http://www.ncbi.nlm.nih.gov/pubmed/9311440.248.McGuire WP, Blessing JA, Moore D, et al.Paclitaxel has moderate activity in squamous cervix cancer.A Gynecologic Oncology Group study.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "根据现有研究，Paclitaxel 这种药物在治疗宫颈鳞状细胞癌中表现出中等程度的有效性。这一结论来自妇科肿瘤小组的一项研究，该研究评估了Paclitaxel在这种类型癌症中的治疗效果。因此，Paclitaxel 可以被认为是一种在治疗宫颈鳞状细胞癌中具有中等活性的药物。",
  "query": "已知一种药物在治疗宫颈鳞状细胞癌中的中等有效性，哪种药物符合这种特征？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 已知一种药物在治疗宫颈鳞状细胞癌中的中等有效性，哪种药物符合这种特征？\n\n<reference text>: Anticancer Drugs 1997;8:657-661.Available at: http://www.ncbi.nlm.nih.gov/pubmed/9311440.248.McGuire WP, Blessing JA, Moore D, et al.Paclitaxel has moderate activity in squamous cervix cancer.A Gynecologic Oncology Group study.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "根据现有研究，Paclitaxel 这种药物在治疗宫颈鳞状细胞癌中表现出中等程度的有效性。这一结论来自妇科肿瘤小组的一项研究，该研究评估了Paclitaxel在这种类型癌症中的治疗效果。因此，Paclitaxel 可以被认为是一种在治疗宫颈鳞状细胞癌中具有中等活性的药物。"
}